4.5 Article

The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients

期刊

JOURNAL OF HEADACHE AND PAIN
卷 23, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s10194-022-01447-3

关键词

Registry; Headache; Migraine; Germany; Acute headache Treatment; Preventive headache Treatment

资金

  1. Projekt DEAL
  2. German Migraine and Headache Society

向作者/读者索取更多资源

Although effective treatment options exist for many headache disorders, not all patients benefit and disability remains significant. To improve headache care, the German Migraine and Headache Society has established the DMKG Headache Registry to observe real-world data. Initial findings show that the majority of participants in the registry have a diagnosis of migraine and experience high levels of headache severity and disability.
Background: Although good treatment options exist for many headache disorders, not all patients benefit and disability continues to be large. To design strategies for improving headache care, real-world data observing standard care is necessary. Therefore, the German Migraine and Headache Society (DMKG) has established the DMKG Headache Registry. Here we present methods and baseline data. Methods: Accredited German headache centers (clinic-based or private practice) can offer participation to their patients. Patients provide headache history, current headache load (including a mobile headache diary), medication and comorbidities and answer validated questionnaires, prior to their physician appointment. Physicians use these data as the base of their history taking, and add, change or confirm some central information. Before the next visit, patients are asked to update their data. Patients will continuously be included over the next years. Results: The present analysis is based on the first 1,351 patients (1110 females, 39.6 +/- 12.9 years) with a completed first visit. Most participants had a migraine diagnosis. Participants had 14.4 +/- 8.5 headache days and 7.7 +/- 6.1 acute medication days per month and 63.9% had a migraine disability assessment (MIDAS) grade 4 (severe disability). 93.6% used at least one acute headache medication, most frequently a triptan (60.0%) or non-opioid analgesic (58.3%). 45.0% used at least one headache preventive medication, most frequently an antidepressant (11.4%, mostly amitriptyline 8.4%) or a CGRP(receptor) antibody (9.8%). Most common causes for discontinuation of preventive medication were lack of effect (54.2%) and side effects (43.3%). Conclusion: The DMKG Headache Registry allows to continuously monitor headache care at German headache centers in both a cross-sectional and a longitudinal approach.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据